Epstein-Barr virus-associated lymphoproliferations and lymphomas

被引:0
|
作者
Anagnostopoulos, I. [1 ]
Joehrens, K. [1 ]
机构
[1] Charite, Inst Pathol, D-10117 Berlin, Germany
来源
PATHOLOGE | 2013年 / 34卷 / 03期
关键词
Herpesvirus; 4; human; Infection; Lymphoproliferation; Lymphoma; Immunodeficiency; PYOTHORAX-ASSOCIATED LYMPHOMA; BURKITTS-LYMPHOMA; INFECTIOUS-MONONUCLEOSIS; CELLS; PROLIFERATION; DISORDERS; FEATURES;
D O I
10.1007/s00292-013-1750-9
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Epstein-Barr virus (EBV) is a lymphotropic herpesvirus infecting > 95 % of the worldwide population. In case of an immunodeficiency of various causes, the virus may lead to the development of a wide spectrum of lymphoproliferations and lymphomas. This encompasses mononucleosis-like lymphoproliferations, hyperplasias of various B-cell subsets as well as aggressive non-Hodgkin lymphomas and classical Hodgkin lymphoma. These lesions occur frequently extranodal and present with a polymorphous histology with angioinvasion and necrosis. Clinical data combined with the immunohistological detection of CD30 expression in the activated infected cells and the demonstration of EBV-encoded proteins and RNA transcripts are helpful for achieving precise classification of these lesions.
引用
收藏
页码:262 / 271
页数:10
相关论文
共 50 条
  • [41] The paradox of Epstein-Barr virus-associated hepatitis
    Negro, F
    JOURNAL OF HEPATOLOGY, 2006, 44 (05) : 839 - 841
  • [42] Immunotherapy for Epstein-Barr virus-associated tumors
    Comito, MA
    Sun, Q
    Lucas, KG
    LEUKEMIA & LYMPHOMA, 2004, 45 (10) : 1981 - 1987
  • [43] IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-ASSOCIATED MALIGNANCIES
    Long, Heather M.
    Parsonage, Gregory
    Fox, Christopher P.
    Lee, Steven P.
    DRUG NEWS & PERSPECTIVES, 2010, 23 (04) : 221 - 228
  • [44] Gene therapy strategies for treating Epstein-Barr virus-associated lymphomas: Comparison of two different Epstein-Barr virus-based vectors
    Kenney, S
    Ge, JQ
    Westphal, EM
    Olsen, J
    HUMAN GENE THERAPY, 1998, 9 (08) : 1131 - 1141
  • [45] Epstein-Barr virus and lymphomas
    Brooks, LA
    Crook, T
    Crawford, DH
    CANCER SURVEYS, 1999, 33 : 99 - 123
  • [46] GENETIC ALTERATIONS INVOLVING PROGRAMMED DEATH LIGANDS IN EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOMAS
    Kataoka, K.
    Hiroaki, M.
    Sakata, S.
    Dobashi, A.
    Couronne, L.
    Kogure, Y.
    Sato, Y.
    Nishida, K.
    Shiraishi, Y.
    Tanaka, H.
    Chiba, K.
    Watatani, Y.
    Shiozawa, Y.
    Yoshida, K.
    Sanada, M.
    Kato, M.
    Miyano, S.
    Ota, Y.
    Izutsu, K.
    Yoshino, T.
    Hermine, O.
    Takeuchi, K.
    Ohshima, K.
    Ogawa, S.
    HAEMATOLOGICA, 2017, 102 : 13 - 13
  • [47] CHARACTERISTIC OF THE EPSTEIN-BARR VIRUS-ASSOCIATED MALIGNANT-LYMPHOMAS IN CHERNOBYL REGION PATIENTS
    BUTENKO, ZA
    KINDZELSKY, LP
    BUTENKO, AK
    SMIRNOVA, IA
    NAUMENKO, OI
    KISHINSKAYA, EG
    SANUKOVA, LN
    EKSPERIMENTALNAYA ONKOLOGIYA, 1992, 14 (06): : 36 - 40
  • [48] Epstein-Barr Virus-Associated B-cell Lymphomas: Pathogenesis and Clinical Outcomes
    Saha, Abhik
    Robertson, Erle S.
    CLINICAL CANCER RESEARCH, 2011, 17 (10) : 3056 - 3063
  • [49] Epstein-Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: a review
    Marques-Piubelli, Mario L.
    Salas, Yessenia I.
    Pachas, Carlos
    Becker-Hecker, Renato
    Vega, Francisco
    Miranda, Roberto N.
    PATHOLOGY, 2020, 52 (01) : 40 - 52
  • [50] Interleukin-10 in Epstein-Barr virus-associated post-transplant lymphomas
    Garnier, JL
    Blanc-Brunat, N
    Vivier, G
    Rousset, F
    Touraine, JL
    CLINICAL TRANSPLANTATION, 1999, 13 (04) : 305 - 312